Dar Al Dawa Development and Investment Co. Ltd. (ASE:DADI)

Market Cap	59.46M +35.9%
Revenue (ttm)	81.56M +0.5%
Net Income	6.61M +84.2%
EPS	0.14 +36.7%
Shares Out	47.19M
PE Ratio	9.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	290,689
Average Volume	204,155
Open	1.240
Previous Close	1.260
Day's Range	1.220 - 1.260
52-Week Range	1.090 - 1.310
Beta	0.25
RSI	63.59
Earnings Date	Feb 12, 2026

About ASE:DADI

Dar Al Dawa Development and Investment Co. Ltd., an integrated pharmaceutical company, develops, manufactures, markets, and distributes pharmaceutical and consumer healthcare products in Levant, Gulf and Yemen, the Middle East, Africa, Europe, and Asia. The company offers products in the therapeutic areas of anti-infective, cardiovascular and diabetes, urology, respiratory, gastrointestinal, analgesic and musculoskeletal, central nervous system, gynecology, dermatology, ophthalmology, and oncology; and cereal and milk formula products for infan...

• Industry: Pharmaceutical Preparations
• Founded: 1975
• Employees: 1,111
• Stock Exchange: Amman Stock Exchange
• Ticker Symbol: DADI

Financial Performance

In 2025, ASE:DADI's revenue was 81.56 million, an increase of 0.47% compared to the previous year's 81.18 million. Earnings were 6.61 million, an increase of 84.25%.